References
- Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993;118(8):622–629. doi:https://doi.org/10.7326/0003-4819-118-8-199304150-00009.
- Devlin NJ, Shah KK, Feng Y, Mulhern B, van Hout B. Valuing health‐related quality of life: An EQ‐5 D‐5 L value set for England. Health Econ 2018;27(1):7–22. doi:https://doi.org/10.1002/hec.3564.
- Nahvijou A, Safari H, Yousefi M, Rajabi M, Arab-Zozani M, Ameri H. Mapping the cancer-specific FACT-B onto the generic SF-6Dv2. Breast Cancer 2021;28(1):130–137. doi:https://doi.org/10.1007/s12282-020-01141-9.
- Excellence NIfC. Guide to the methods of technology appraisal. 2008. Available from: http://wwwniceorguk/aboutnice/howwework/devnicetech/technologyappraisalprocessguides/guidetothemethodsoftechnologyappraisaljsp [last accessed 11 March 2020].
- Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002;21(2):271–292. doi:https://doi.org/10.1016/S0167-6296(01)00130-8.
- Jenkinson C, Layte R. Development and testing of the UK SF-12. J Health Serv Res Policy 1997;2(1):14–18. doi:https://doi.org/10.1177/135581969700200105.
- Horsman J, Furlong W, Feeny D, Torrance G. The Health Utilities Index (HUI®): concepts, measurement properties and applications. Health Qual Life Outcomes 2003;1(1):54. doi:https://doi.org/10.1186/1477-7525-1-54.
- Whitehead SJ, Ali S. Health outcomes in economic evaluation: The QALY and utilities. Br Med Bull 2010;96(1):5–21. doi:https://doi.org/10.1093/bmb/ldq033.
- Weinstein MC, Torrance G, McGuire A. QALYs: The basics. Value Health 2009;12:S5–S9. doi:https://doi.org/10.1111/j.1524-4733.2009.00515.x.
- Pizzi LT. The Institute for Clinical and Economic Review and its growing influence on the US healthcare. Am Health Drug Benefits 2016;9(1):9.
- Group TE. EuroQol-A new facility for the measurement of health-related quality of life. Health Policy 1990;16(3):199–208.
- Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011;20(10):1727–1736. doi:https://doi.org/10.1007/s11136-011-9903-x.
- Buchholz I, Janssen MF, Kohlmann T, Feng Y-S. A systematic review of studies comparing the measurement properties of the three-level and five-level versions of the EQ-5D. Pharmacoeconomics 2018;36(6):645–661. doi:https://doi.org/10.1007/s40273-018-0642-5.
- Yousefi M, Safari H, Sari AA, Raei B, Ameri H. Assessing the performance of direct and indirect utility eliciting methods in patients with colorectal cancer: EQ-5D-5L versus C-TTO. Health Serv Outcomes Res Method 2019;19(4):259–270. doi:https://doi.org/10.1007/s10742-019-00204-5.
- Nahvijou A, Safari H, Ameri H. Comparing the performance of the EQ-5D-5L with two versions of the SF-6Dv2 in patients with breast cancer. Health Serv Outcomes Res Method 2020;20(2-3):183–194. doi:https://doi.org/10.1007/s10742-020-00215-7.
- Ameri H, Safari H, Yousefi M. Interim value set for the EQ-5D-5L in Iran using the Crosswalk method. Med J Islamic Republic Iran 2020;34:121. doi:https://doi.org/10.34171/mjiri.34.121.
- Mulhern B, Pink J, Rowen D, Borghs S, Butt T, Hughes D, Marson A, Brazier J. Comparing generic and condition-specific preference-based measures in epilepsy: EQ-5D-3L and NEWQOL-6D. Value Health 2017;20(4):687–693. doi:https://doi.org/10.1016/j.jval.2016.03.1860.
- WHO Organization. Available from: https://www.who.int/news-room/fact-sheets/detail/asthma [last accessed 10 November 2020].
- Masoli M, Fabian D, Holt S, Beasley R, Global Initiative for Asthma (GINA) Program. The global burden of asthma: Executive summary of the GINA Dissemination Committee report. Allergy 2004;59(5):469–478. doi:https://doi.org/10.1111/j.1398-9995.2004.00526.x.
- Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med 2009;151(4):264–269. doi:https://doi.org/10.7326/0003-4819-151-4-200908180-00135.
- Mitton C, Adair CE, McKenzie E, Patten SB, Perry BW. Knowledge transfer and exchange: Review and synthesis of the literature. Milbank Q 2007;85(4):729–768. doi:https://doi.org/10.1111/j.1468-0009.2007.00506.x.
- Cronbach LJ, Meehl PE. Construct validity in psychological tests. Psychol Bull 1955;52(4):281–302. doi:https://doi.org/10.1037/h0040957.
- Terwee CB, Prinsen CAC, Chiarotto A, Westerman MJ, Patrick DL, Alonso J, Bouter LM, de Vet HCW, Mokkink LB. COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study. Qual Life Res 2018;27(5):1159–1170. doi:https://doi.org/10.1007/s11136-018-1829-0.
- Carmines EG, Zeller RA. Reliability and validity assessment. Sage publications; 1979.
- Bousquet J, Hellings PW, Agache I, Bedbrook A, Bachert C, Bergmann KC, Bewick M, Bindslev-Jensen C, Bosnic-Anticevitch S, Bucca C, et al. ARIA 2016: care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clin Transl Allergy 2016;6(1):1–14. doi:https://doi.org/10.1186/s13601-016-0137-4.
- Whalley D, Globe G, Crawford R, Doward L, Tafesse E, Brazier J, Price D. Is the EQ-5D fit for purpose in asthma? Acceptability and content validity from the patient perspective. Health Qual Life Outcomes 2018;16(1):160. doi:https://doi.org/10.1186/s12955-018-0970-3.
- Richardson J, Iezzi A, Khan MA, Chen G, Maxwell A. Measuring the sensitivity and construct validity of 6 utility instruments in 7 disease areas. Med Decis Making 2016;36(2):147–159. doi:https://doi.org/10.1177/0272989X15613522.
- Hernandez G, Garin O, Dima AL, Pont A, Martí Pastor M, Alonso J, Van Ganse E, Laforest L, de Bruin M, Mayoral K, et al., ASTRO-LAB Group. EuroQol (EQ-5D-5L) validity in assessing the quality of life in adults with asthma: cross-sectional study. J Med Internet Res 2019;21(1):e10178. doi:https://doi.org/10.2196/10178.
- Crossman-Barnes C-J, Sach T, Wilson A, Barton G. The construct validity and responsiveness of the EQ-5D-5L, AQL-5D and a bespoke TTO in acute asthmatics. Qual Life Res 2020;29(3):619–627. doi:https://doi.org/10.1007/s11136-019-02345-z.
- Crossman-Barnes C-J, Sach T, Wilson A, Barton G. Estimating loss in quality of life associated with asthma-related crisis events (ESQUARE): a cohort, observational study. Health Qual Life Outcomes 2019;17(1):58. doi:https://doi.org/10.1186/s12955-019-1138-5.
- Bittner C, Garrido M, Harth V, Preisser A. IgE reactivity, work related allergic symptoms, asthma severity, and quality of life in bakers with occupational asthma. In: Allergy and Respiration. Springer; 2016:51–60.
- Efthymiadou O, Mossman J, Kanavos P. Health related quality of life aspects not captured by EQ-5D-5L: Results from an international survey of patients. Health Policy 2019;123(2):159–165. doi:https://doi.org/10.1016/j.healthpol.2018.12.003.
- Johnson PT, Bell CF, White J, Essoi B, Nelsen L, Averell CM. Observational vignette study to examine patient and healthcare provider perceived impact of asthma-related exacerbations in the US. Multidiscip Respir Med 2019;14(1):32. doi:https://doi.org/10.1186/s40248-019-0196-1.
- Lucas C, Aly S, Touboul C, Sellami R, Guillaume X, Garcia G. Patient-reported outcome in two chronic diseases: A comparison of quality of life and response profiles in severe migraine and severe asthma. PROM 2020;11:27–37. doi:https://doi.org/10.2147/PROM.S222597.
- Arab-Zozani M, Hashemi F, Safari H, Yousefi M, Ameri H. Health-related quality of life and its associated factors in COVID-19 patients. Osong Public Health Res Perspect 2020;11(5):296–302. doi:https://doi.org/10.24171/j.phrp.2020.11.5.05.
- Su M, Hua X, Wang J, Yao N, Zhao D, Liu W, Zou Y, Anderson R, Sun X. Health-related quality of life among cancer survivors in rural China. Qual Life Res 2019;28(3):695–702. doi:https://doi.org/10.1007/s11136-018-2038-6.
- Pickard AS, Wilke C, Jung E, Patel S, Stavem K, Lee TA. Use of a preference-based measure of health (EQ-5D) in COPD and asthma. Respir Med 2008;102(4):519–536. doi:https://doi.org/10.1016/j.rmed.2007.11.016.
- Hazell M, Frank T, Frank P. Health related quality of life in individuals with asthma related symptoms. Respir Med 2003;97(11):1211–1218. doi:https://doi.org/10.1016/S0954-6111(03)00249-X.
- Chen H, Gould MK, Blanc PD, Miller DP, Kamath TV, Lee JH, Sullivan SD. Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease. J Allergy Clin Immunol 2007;120(2):396–402. doi:https://doi.org/10.1016/j.jaci.2007.04.040.
- Lee LK, Ramakrishnan K, Safioti G, Ariely R, Schatz M. Asthma control is associated with economic outcomes, work productivity and health-related quality of life in patients with asthma. BMJ Open Resp Res 2020;7(1):e000534. doi:https://doi.org/10.1136/bmjresp-2019-000534.
- Terzano C, Cremonesi G, Girbino G, Ingrassia E, Marsico S, Nicolini G, Allegra L, on behalf of the PRISMA (PRospectIve Study on asthMA control) Study Group. 1-Year prospective real life monitoring of asthma control and quality of life in Italy. Respir Res 2012;13(1):112. doi:https://doi.org/10.1186/1465-9921-13-112.
- Szende A, Leidy N, Ståhl E, Svensson K. Estimating health utilities in patients with asthma and COPD: evidence on the performance of EQ-5D and SF-6D. Qual Life Res 2009;18(2):267–272. doi:https://doi.org/10.1007/s11136-008-9429-z.